Robustness of NanoBiT luciferase complementation technology in the presence of widely used kinase inhibitors. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.slasd.2022.09.004
PubMed Identifier: 36162794
Publication URI: http://europepmc.org/abstract/MED/36162794
Type: Journal Article/Review
Volume: 27
Parent Publication: SLAS discovery : advancing life sciences R & D
Issue: 8
ISSN: 2472-5552